Arterial disease and venous thromboembolism: A modern paradigm?

Thrombosis and Haemostasis

Volumn 96, Issue 2, 2006, Pages 111-112

  Goon, Patrick K Y ^a   Lip, Gregory Y H ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANTICOAGULANT THERAPY; ARTERY THROMBOEMBOLISM; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; ECHOGRAPHY; EDITORIAL; HEART INFARCTION; HUMAN; IDIOPATHIC DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM; THROMBOGENESIS; VENOUS THROMBOEMBOLISM;

HUMANS; RISK FACTORS; THROMBOEMBOLISM; THROMBOSIS; VASCULAR DISEASES; VENOUS THROMBOSIS;

EID: 33747093700     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-07-0380     Document Type: Editorial

References (15)

1. Choudhury A, Lip GYH. Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice. Pathophysiol Haemost Thromb 2003/2004; 33: 282-9.
2. Lip GYH, Varma C. Anticoagulation plus aspirin following acute myocardial infarction: Yes or no ... and if the latter, why not? Thromb Res 2005 Nov 4; [Epub ahead of print] doi:10.1016/j.thromres.2005.09.012.
3. Tsaloumas MD, Kirwan J, Vinall H, et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye 2000; 14: 821-7.
4. Lee KW, Lip GYH. Acute coronary syndromes: Virchow's triad revisited. Blood Coagul Fibrinolysis 2003;14: 605-25.
5. Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Eng J Med 2003; 348: 1435-41.
6. Bova C, Marchiori, A, Noto A, et al. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. Thromb Haemost 2006; 132-6.
7. Blann AD, Lip GY. Venous thromboembolism. BMJ 2006; 332: 215-9.
8. Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348: 1435-41.
9. Maier W, Altwegg LA, Corti R, et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005;111: 1355-61.
10. Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996; 127: 263-71.
11. Rus HG, Niculescu F, Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991; 89: 247-54.
12. Reitsma PH, Rosendaal FR. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2004; 2: 619-22.
13. van Aken BE, Reitsma PH, Rosendaal FR. Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 2002; 116: 173-7.
14. Lip PL, Blann AD, Jones AF, et al. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Eye 1998; 12: 245-51.
15. Ray JG, Mamdani M, Tsuyuki RT, et al. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 2001; 161: 1405-10.